Main Article Content
Introduction: Heterogeneity in sickle cell anaemia manifestations ranges from near asymptomatic cases to severe illness.
Objective: This study determined the relationship between foetal haemoglobin F level, other haematological parameters and acute painful episode score of sickle cell disease patients in FCT Abuja Nigeria.
Methods: 60 Sickle cell patients were selected for the study. 20 severe crises, 20 non-severe crisis SS were enrolled in the study. Control group comprised 20 apparently healthy haemoglobin AA individuals. Data were analysed descriptively.
Results: Hb F level increased significantly in non-severe crisis sickle cell anaemia (7.12%± 3.6) and severe crisis (5.30%±2.3) groups, compared to the control group (0.32±1.8). This trend was also observed in RDW, MCHC and MCV. The mean Hb concentration and haematocrit (Hct) were significantly lower for both non- severe crisis and severe crisis SCA groups. There was no significant correlation between HbF and any of the haematological parameters in both non severe crisis and severe crisis groups. Patients with SCA had higher levels of HbF than matched controls. HbF had no correlation with any of the haematological parameters in both severe and non-severe SCA groups studied.
Conclusion: Further studies should focus on environmental factors contributing to this variability.
World Health Organisation; sickle-cell anaemia. Agenda item 11.4 in 59 World Health Assembly, Geneva; World Health Organization; 2006.
Alawi H, Martin H, Steinberg M, Genetic basis of heterogeneity and severity in sickle cell disease. Experimental Biology and Medicine (Maywood). 2016;241(7): 689-698.
Makani J, Ofori-Acquah SF, Nnodu O, Klonkam A, Ohene- Frempong K. Sickle Cell disease: New opportunities and challenges in Africa; 2013.
Tewari S, Brousse V, Piel FB, Menzel S, Rees DC. Environmental determinants of severity in sickle cell disease. Haematological. 2015;100:1108–16.
Ngo DA, Aygun B, Akinsheye I, Hankins JS, Bhan I, Luo HY. Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin. Br J Haematol. 2012;156:25964.
Steinberg MH, Chui DH, Dover GJ, Sebastiani P, Alsultan A. Fetal hemoglobin in sickle cell anemia: A glass half full? Blood. 2014;123:481-5.
Idowu A, Abdulrahman A, Nadia S, Duyen N, Clinton T, Baldwin, Poala S, David HK. Foetal haemoglobin in sickle cell anaemia. Blood. 2011;118(1):19-27.
Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, dCastro, O. Barton, F. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. American Journal of Hematolog. 2003;72:121–126.
Platt OS, Brambilla DJ, Rosse WF. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 1994;330(23):1639-1644.
Morenike AA, Samuel AA, Saheed BO, Oluwagbemiga OA. Relationship between foetal haemoglobin and haematological indices in children with sickle cell anaemia from South Western Nigeria. Nigerian Postgraduate Medical Journal. 2017:24(4): 195-200.
Olaniyi JA, Arinola OG, Odetunde AB, Foetal haemoglobin status in adult sickle cell anaemia patients in Ibadan Nigeria. Annals of Ibadan Postgraduate Medicine. 2010;8(1):30-33.
Ofori-Acquah SF, Lalloz MR, Serjeant G, Layton DM. Dominant influence of gamma-globin promoter polymorphisms on fetal haemoglobin expression in sickle cell disease. Cell Mol Biol (Noisy-le-grand). 2004;50(1):35–42.
Robert S. Franco, Zahida Yasin, Mary B. Palascak, Peter Ciraolo, Clinton H. Joiner, Donald L. Rucknagel. The effect of foetal haemoglobin on the survival characteristics ofsickle cells. Blood. 2006;108(3):1073-1076.
Thein SL. Genetic association studies in beta-hemoglobinopathies. Hematol Am Soc Hematol Educ Program. 2013;354–361.
Adekile AD. Sickle cell disease in Kuwait. Hemoglobin. 2001;25(2):219–225.